Peripheral artery disease (PAD) affects an estimated 8.5 million adults in the United States. 1 Complaints of claudication, defi ned as pain or cramping with walking, or other atypical leg symptoms such as fatigue with activity are reported by up to 60% of individuals with PAD. 2 Consequently, individuals with PAD also commonly experience limitations across all domains of function including slow gait speeds, 3 balance dysfunction, 4 decreased leg strength, 5 and a sedentary lifestyle. 3 These result in low ambulatory activity levels 6 and the associated potential for weight gain, obesity, 7 , 8 and worsening PAD.
Research Report with a body mass index (BMI) of more than 30 kg/m 2 are twice as likely to develop mobility limitations as nonobese individuals. 15 While both obesity and PAD seem to be independent threats to mobility function, they seem to work additively to maximize disability. Individuals who are obese and diagnosed with PAD claudicate more quickly with activity, 9 require longer time to recover after exercise, 9 and also experience greater declines in calf muscle area, 6-minute walk distance (6MWD), and gait speed than normal-weight individuals with PAD. [9] [10] [11] Exercise interventions are known to signifi cantly improve walking distance and mobility function in both obese older adults and those with PAD. 16 An on-site, supervised walking program of at least 3 months in duration is recommended for adults with PAD, 17 as virtually all studies have found improved exercise tolerance, increased time to the onset of claudication (COT) and 6MWD, and faster walking speeds. [18] [19] [20] An early meta-analysis found that exercise programs of at least 6 months in duration were more optimal in improving exercise tolerance and COT, 21 which could provide the necessary exercise volume for adults with PAD and high comorbid burden, such as those with obesity, to benefi t from an exercise program. Obesity may attenuate the typical mobility improvements found with an exercise intervention. 22 In the non-PAD population, compared with older adults with obesity, older adults without obesity improve up to fi ve times greater in walking speed after an exercise intervention. 22 A direct comparison of the effects of exercise intervention on individuals with PAD who are obese and nonobese has not been examined. Therefore, the purpose of this study was to compare the effects of a 6-month, centerbased, supervised treadmill walking program on mobility and PAD-specifi c measures of function between older adults who have PAD and are weight-stable obese and nonobese. We hypothesized that weight-stable, obese adults would experience smaller improvements in function after a walking intervention when compared with adults who are not obese.
METHODS
This is a secondary data analysis taken from previous work 18 , 19 , 23 , 24 conducted as part of the Claude D. Pepper Older Americans Independence Center at the University of Maryland, Baltimore. Two studies were combined for this data set. One trial was a randomized control trial of exercise versus standard of care in current nonsmokers 18 and the other was an exercise study in both smokers and nonsmokers that did not involve a standard-of-care group. 24 Both exercise interventions were identical. Only individuals with complete data from baseline and follow-up testing for all variables of interest in this study were included in this analysis. Of the 72 individuals originally enrolled in the study, 11 individuals withdrew during baseline testing and an additional 8 individuals were excluded from this analysis because of incomplete data, leaving 53 outpatient volunteers with a history of PAD and intermittent claudication but free from rest pain (Fontaine Stage II). All individuals were recruited from the community or outpatient clinics and completed participation in a 6-month, centerbased treadmill training study as previously published. 18 , 19 Written informed consent was obtained from each participant, and all procedures were approved by the Institutional Review Board at the University of Maryland, Baltimore.
Study Overview
Individuals were included if they were community-dwelling adults, older than 60 years, experienced intermittent claudication during a treadmill test, and had a resting ankle brachial index (ABI) of less than 0.97, 25 with evidence of a decline in ABI more than 20% after exercise. 26 Exclusion criteria included claudication pain at rest, exercise tolerance limited by factors other than claudication pain (eg, severe coronary artery or respiratory disease), substance abuse, dementia, or any poorly controlled medical conditions that would limit participation in exercise (eg, hypertension, pulmonary disease, and severe arthritis). All individuals underwent a comprehensive medical evaluation including a medical history, complete blood count, fasting plasma glucose and lipid concentrations, liver and renal function, a screening maximal effort treadmill test, and medication review performed by a study physician, before enrollment to ensure individuals met all inclusion/exclusion criteria. After all baseline testing was complete, individuals participated in a 6-month supervised treadmill program or a standard-of-care nonexercise group depending on the study. Follow-up testing was performed by study personal blinded to the group assignment of participants.
Exercise Protocol
The exercise program, as previously described, consisted of 6 months of supervised, intermittent treadmill walking to near maximal claudication pain 3 days per week. 19 Briefl y, participants' vitals (heart rate, blood pressure, and blood glucose) were initially taken to ensure they were safe to exercise. Participants began their exercise program by walking for 15 minutes and progressed to 45 minutes of walking. Participants were asked to walk until near maximal claudication pain had been reached. When participants could no longer walk due to maximal claudication pain, they were allowed to rest until pain had subsided and then asked to walk again. This cycle was repeated until the required number of minutes for walking had been accumulated.
Standard of Care
The standard-of-care group continued to receive all usual care from their physicians and was not given any recommendations concerning exercise or walking.
Participant Characteristics, Functional, and Measures
The following demographic, functional, and mobility measures were obtained in both groups before and after the 6-month intervention period of the study. BMI was calculated as weight in kilograms divided by height in square meters (kg/m 2 ).
Maximal treadmill test
Participants performed a progressive, graded treadmill protocol (2 mph, 0% grade with 2% increase every 2 minutes) until maximal claudication pain was reached on 2 separate occasions. 19 The fi rst test (screening treadmill) determined whether walking performance was limited by claudication pain with concomitant decrease in ABI for study inclusion; the second test determined claudication onset time (COT), defi ned as the walking time that patients fi rst experienced claudication pain; peak walking time (PWT), defi ned as the walking time at which ambulation could not continue due to maximal claudication pain.
6-minute walk distance
All participants completed an overground 6-minute walk test on a day separate from the treadmill tests as described previously pre-and post-intervention, and the total distance achieved (6MWD) was recorded. 20 , 27 Walking Impairment Questionnaire Self-reported ambulatory ability was assessed with the Walking Impairment Questionnaire (WIQ). The WIQ assess a participant's self-reported walking ability in 3 subscales: distance, speed, and stairs. 28 
Statistical Analysis
Individuals were divided into the following 4 groups based on their baseline BMI and randomization: (1) exercise nonobese (Ex), (2) exercise obese (ExO), (3) standard-ofcare nonobese (SC), and (4) standard-of-care obese (SCO).
Obesity was defi ned as a baseline BMI of 30 kg/m 2 or more. All statistical analyses were performed using IBM SPSS Statistics v 20.0 (IBM, Armonk, New York). Independent t tests were used to compare baseline functional mobility scores between the obese and nonobese groups. Analysis of covariance with a 2 × 2 design (exercise group × obesity), co-varying for baseline scores, was used to analyze group differences in the changes for each measure (COT, PWT, 6MWD, and WIQ scores). When a main effect of exercise was found, paired t tests were used to test for signifi cant changes within each group. When signifi cant interactions were found, least signifi cant difference post-hoc tests were used to test for different changes among the 4 groups. Data are presented in all tables as the mean (standard error of the mean [SEM]). The SEM was used as a measure of precision of the estimated population mean. The level of statistical signifi cance was set at P < .05.
RESULTS

Baseline Functional Differences in Obese and Nonobese Patients With PAD
A total of 37 individuals without obesity and 16 individuals with obesity completed their assigned 6-month intervention and all testing. Demographics can be found in Table 1 . During the baseline treadmill test, individuals with obesity demonstrated an approximately 30% earlier COT and a 33% shorter PWT ( P < .05) compared with individuals without obesity ( Table 2 ) . Individuals with obesity also reported 30% lower function on the speed portion of the WIQ ( P = .03). Although neither 6MWD, nor WIQ distance or stairs reached the level of statistical signifi cance, there was a tendency for lower function for individuals with obesity. The 6MWD of obese individuals Research Report was approximately 30 m less than nonobese ( P = .1), and they also reported 25% to 30% more diffi culty with walking various distances ( P = .1) and with climbing stairs ( P = .06) on the WIQ than individuals without obesity. ( Table 3 ) Post-hoc division into groups resulted in 28 Ex, 8 ExO, 9 SC, and 8 SCO participants. The majority of participants in all groups were male. Both exercise groups had a significantly higher percentage of individuals who were current smokers ( P = .01). Resting ABIs and the percentage of individuals with hypertension, dyslipidemia, diabetes, or a previous revascularization procedure were not signifi cantly different between any of the groups. For both the 6MWD and WIQ stairs, there was a signifi cant ( P < .01) exercise × obesity interaction effect, with both exercise groups making signifi cant ( P < .05) improvements. Post-hoc testing revealed that the SCO group was different from all other groups for both the 6MWD and WIQ stairs. The SCO group demonstrated a tendency toward decreased function with an 18% decrease in the 6MWD compared with baseline ( P = .06) and a 16% reported decline on the WIQ stairs compared with baseline, although this did not reach statistical signifi cance. The SC group did not make any signifi cant changes baseline to post-testing.
Changes in Function With Exercise Intervention
For both PWT and COT, signifi cant exercise effects were seen. Both exercise intervention groups improved ( P < .001) similarly for PWT, whereas no signifi cant change was seen in either the SC or SCO groups. For COT the Ex group was the only group to signifi cantly improve ( P < .001). No signifi cant change was found in any other group. No signifi cant interaction, exercise, or obesity effect was found for the WIQ distance or WIQ speed.
DISCUSSION
Obesity negatively impacts mobility and function in older adults and those with PAD. 9-11 , 29 Previous work demonstrates that obesity may blunt the effect of exercise interventions in older adults without PAD 22 , 30 ; however, until now the impact of obesity on changes in function after an exercise intervention in older adults with PAD was unexplored. Our primary fi nding, contrary to our initial hypothesis, was that older adults with PAD experience similar improvements in function despite obesity status after 6 months of a supervised exercise program. We found similar improvements in PWT and 6MWD in both the ExO and Ex groups. Conversely, we also found older adults with PAD and obesity in the SCO group experience declines in mobility function, whereas those without obesity in the SC group did not appear to increase nor decrease their function.
Mobility Improves After an Intervention But Is Still Below Healthy Norms
Walking and aerobic exercise programs enhance function in individuals with PAD. We and others have previously demonstrated that 6 months of intervention results in improved mobility including improved COT, PWT, and 6MWD. 18-20 , 31 , 32 In this study we found that nonobese individuals improved their 6MWD by 28 m whereas the obese group improved by almost 60 m. Previous work defi nes a small but meaningful change in 6MWD as 20 m and a large meaningful change as 50 m. 33 On the basis of these values, both of our intervention groups made clinically meaningful improvements in their 6MWD. The ExO group further improved their PWT on the treadmill by more than 6 minutes, indicating an increase in maximal workload because the treadmill test has an increase in workload every 2 minutes. The 4-to 7-minute increase found in the exercise groups in PWT is a clinically important increase representing a 25% to 50% increase in work capacity compared with baseline. This potentially represents an increased ability to perform higher intensity tasks as well as improved endurance in day-to-day life. This premise is supported by the fact that both exercise groups also reported an improved ability to navigate stairs, as refl ected in higher WIQ stair scores.
Although the exercise groups clearly improved in function, it is important to note that, despite these signifi cant improvements after the intervention, all groups in this study still had values of 6MWD that were more than 20% below the norms for healthy community-dwelling older individuals. 34 Even after 6 months of intervention, both exercise groups were far below the 527-m norms for 6MWD reported in healthy community-dwelling older adults 34 and actually performed similar to other impaired older adult populations, such as those who have suffered a stroke. 35 This lower functional status, even after an exercise intervention, places adults with PAD at an increased risk for mobility loss, 36 sedentary lifestyle, and ultimately increased mortality. [36] [37] [38] 
Obese Individuals Demonstrate Lower Baseline Function and Experience Large Declines in Function Without an Intervention
Obese individuals in this study were at a functional disadvantage from the outset, demonstrated by lower COT and a trend toward lower scores in most other measures at baseline compared with nonobese participants. This fi nding is in agreement with previous longitudinal fi ndings where obese individuals with PAD experienced greater declines in mobility function over time compared with nonobese individuals. 10 A particularly interesting observation from this study was that the SCO group, but not the SC group, experienced signifi cant declines in function as evident by decreased 6MWD and WIQ stair scores. A particularly noteworthy observation was that the 6MWD of the SCO group decreased by an average of 65 m over 6 months, which is a substantial and clinically meaningful change. 33 This large decline in 6MWD places obese individuals with PAD who do not exercise at particular risk for mobility limitation. We also noted a trend toward decreasing WIQ stair scores in this group; though not statistically signifi cant, this decrease is still concerning, as declining WIQ scores have been associated with higher all-cause mortality in those with PAD. 37 , 39 In contrast, (7) 53 (7) 14 (6) 14 (6) Exercise × obesity P = .18 Exercise P = .19 ExO 41 (14) 63 (13) 22 (10) 23 (10) SC 47 (13) 58 (11) 14 (10) 14 ( (6) 51 (5) 13 (5) 13 (5) Exercise × obesity P = .15 Exercise P = .11 ExO 29 (6) 56 (12) 23 (8) 23 (8) SC 42 (6) 52 (9) 12 (7) 12 (7) SCO 27 (7) 27 (7 (6) 65 (5) 18 (5) 17 (5) c Exercise × obesity P = .01 Exercise P = .006 ExO 50 (7) 80 (10) 30 (9) 30 (9) Research Report the nonobese standard-of-care group did not experience declines in mobility or PAD-specifi c reported function. Our fi ndings expand on previous work and suggest that exercise interventions may be particularly important in obese individuals with PAD to not only prevent declines in mobility, but to also improve mobility to a similar extent as their nonobese counterparts.
Possible Mechanisms of Change and Future Work
Although the mechanisms behind the improvements with exercise and the converse declines in function in the SCO group in this study are unknown, it is plausible that changes in a number of factors such as infl ammatory levels, 40 intramuscular adipose tissue, 41 peripheral circulation, 42 or metabolic demand 42 during walking may have contributed to the improvements in function found in both the obese and nonobese intervention groups. 42 It is also plausible that same mechanisms acted synergistically with obesity and PAD ultimately resulting in decreased mobility function over 6 months in individuals in the SCO group but not in the SC group. Although this is speculative, as we did not measure any mechanisms of change in this study, future studies should determine the mechanisms behind functional and mobility changes in obese and nonobese individuals with PAD. Given that even after 6 months of intervention, both obese and nonobese individuals lag functionally behind the norms for healthy adults, additional interventions may be necessary for individuals with PAD. Resistance exercise is an effective method of improving mobility function in older adults and those with PAD, 20 , 43 and the addition of resistance exercise to a walking program may prove useful in further improving mobility function. Furthermore, prior work has demonstrated that in older obese frail adults, the combination of weight loss and exercise in obese individuals is more effective at improving mobility and function compared with exercise alone. 44 , 45 Although the benefi ts of intentional weight loss have not yet been explored in PAD, our fi ndings, in combination with previous work in obese older adults, suggest that weight loss may be a useful adjunct in obese individuals with PAD to further improve mobility and function.
Study Limitations
Although this is a novel report from a 6-month longitudinal study, there are several limitations. First, division into obese and nonobese groups occurred post-hoc rendering a relatively small number of individuals in the groups. Second, we did not examine any mechanisms related to the decreases in function in the obese standard-of-care group; thus, we are unable to make any statements concerning the reasons behind the decreased function. We also had a limited number of functional measurements and differences between the number of current smokers in the 4-groups. Although our functional measures are appropriate and specifi c for PAD, we recognize that smoking status may infl uence our functional outcomes. However, as all current smokers were only in the intervention groups, it is likely that the difference between those who exercised and those in the standard-of-care group would actually have been larger had smokers been included in all groups. Another limitation is that patients volunteered to participate in this study. Thus, a self-selection bias may exist because they may represent those who had greater interest participating, better access to transportation to the research center, and better health than PAD patients who did not volunteer. The results of this study are also only generalizable to patients with symptomatic PAD, and may not be applicable to patients with less severe or more severe PAD. Finally, our nonobese groups were overweight on average, which may have limited our ability to detect difference in exercisemediated changes in function compared with the obese groups. It is possible that a group of normal-weight patients with PAD may respond to exercise to a greater extent than either overweight or obese patients, but we did not have enough individuals in the normal-weight category to make this comparison. Nevertheless our fi nding that both obese and nonobese individuals make similar improvements in function with a 6-month exercise intervention is important, as is the fi nding that obese individuals who do not exercise appear to be at a greater risk for declines in mobility function. Interventions to prevent functional defi cits in obese individuals with PAD should be sought.
CONCLUSIONS AND CLINICAL SIGNIFICANCE
Obese and nonobese individuals with PAD made similar improvements after a 6-month, center-based walking program. However, obese patients with PAD who do not exercise may be susceptible to greater declines in mobility. Exercise may be particularly important in obese patients with PAD to avoid declines in mobility.
